Ward J M, Hodgson J E
SmithKline Beecham Pharmaceuticals, Brockham Park Research Centre, Betchworth, Surrey, UK.
FEMS Microbiol Lett. 1993 Jun 15;110(2):239-42. doi: 10.1111/j.1574-6968.1993.tb06326.x.
The cosmid cloning vector pHC79 has been used to clone fragments of chromosomal DNA from the Streptomyces: S. clavuligerus, S. jumonjinensis and S. katsurahamanus. These strains all produce both the beta-lactam antibiotic, cephamycin and the beta-lactamase inhibitor, clavulanic acid. Although structurally related these two beta-lactams are known to be derived from different biosynthetic precursors. Hybridisation studies and restriction mapping have shown that the gene clusters encoding the two biosynthetic pathways are chromosomally adjacent in these strains, thus creating a 'super-cluster' of genes involved in both the production and enhancement of activity of a beta-lactam antibiotic.
黏粒克隆载体pHC79已被用于克隆来自链霉菌属的染色体DNA片段:克拉维链霉菌、住吉链霉菌和胜红链霉菌。这些菌株均能产生β-内酰胺抗生素头霉素和β-内酰胺酶抑制剂克拉维酸。虽然这两种β-内酰胺在结构上相关,但已知它们来自不同的生物合成前体。杂交研究和限制性图谱分析表明,编码这两种生物合成途径的基因簇在这些菌株的染色体上相邻,从而形成了一个参与β-内酰胺抗生素生产和活性增强的“超级基因簇”。